Skip to content

Glycemic Effects of Meals - Repeatability Trial With Continuous Glucose Monitoring

Glycemic Effects of Meals - Repeatability Trial With Continuous Glucose Monitoring

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07293143
Acronym
GEM-RT CGM
Enrollment
20
Registered
2025-12-19
Start date
2027-01-01
Completion date
2027-12-01
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Response

Keywords

Continuous glucose monitoring (CGM), Post prandial glucose, Fasting blood glucose, Hemoglobin (Hb)A1c, CGM-based dietary challenges, Metabolic risk

Brief summary

Almost half of adults in the United States have either diabetes mellitus (DM) or prediabetes (preDM), but many are undiagnosed and unaware of their condition. Current DM diagnosis and risk prediction are based on single "snapshot" measurements including: fasting blood glucose, postprandial glucose, and hemoglobin (Hb)A1c. Continuous glucose monitoring (CGM) offers a dynamic view of glucose levels throughout the day which enables characterizing individuals' dynamic glycemic profiles in response to physiological and environmental stimuli better than the conventional point-in-time glucose quantification approaches. By analyzing glycemic patterns from CGM tracings, it may be possible to identify individuals at increased risk of developing diabetes. However, an important prerequisite is to establish the reliability and consistency of glucose response patterns captured by CGM under controlled conditions. Participants will be given six different meals to examine the glucose responses to these meals. Two of these meals (white rice and an Ensure drink) will be given twice for each participant to investigate whether individuals have the same glucose response to the same meal given on different days. Glucose will be measured using continuous glucose monitors, that have a thin wire sensor that measures glucose under the skin every five minutes for up to 10 days.

Detailed description

This is a pilot study in which each participant undergoes six meal challenges (one each morning) under free-living conditions, while wearing a blinded CGM sensor. Glucose levels will be continuously measured, and meal challenge sequence will be randomly assigned to each participant. The study objectives are to: 1. determine the within meal replicability of postprandial glucose response to a Ensure and White Rice meal challenges 2. evaluate if a whole food meal challenge (White Rice) exhibits lower reliability and greater physiological variability (under the chewing vs. not chewing condition) in postprandial glucose response compared to a standardized liquid mixed meal tolerance test (Ensure) 3. compare the postprandial average peak glucose response and 4 hour incremental area under the curve (iAUC) for the Ensure tolerance test, mountain dew tolerance test, White Rice, and typical breakfast. These findings will inform the design of future studies and the potential use of CGM-based dietary challenges for early detection of metabolic risk.

Interventions

OTHERSix meal challenges

Two of the meal challenges will only be provided once: (1) a 20oz bottle of Mountain Dew (2) a "typical breakfast" that participants would eat normally. The other four challenges consist of two meal events that will each be repeated: (1) two 8-ounce bottles of Ensure® nutritional shake (2) one cup of microwaved white rice (microwaveable Minute brand Jasmine Rice cups). The rice challenge will be performed once with normal chewing and once by swallowing without chewing, while the Ensure challenge will be repeated the same way on both days.

Sponsors

Boston University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This is a pilot study where the order of the six study meals will be randomly assigned.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Generally healthy * English speaking

Exclusion criteria

* Prior diagnosis of diabetes or taking medications that influence glucose metabolism, such as insulin, glucocorticoids, or Glucagon-like peptide-1 (GLP-1) receptor agonists. * Taking hydroxyurea medication * Taking beyond the maximum dose of acetaminophen (4g/day) * Known food allergies or severe sensitivities to any study materials (dairy or soy) * Limited and non-readers * Cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Glycemic patterns from CGMbaseline, every 4 hours for 6 daysBeginning at baseline, a 4-hour incremental area under the glucose curve (iAUC) will be calculated using the trapezoidal method. Peak glucose will be defined as the maximum glucose excursion within the 4-hour window. Continuous glucose monitoring (CGM) CGM values are recorded every 5 minutes, so linear interpolation will be used to provide a CGM value every minute to line up with the ingestion time documented in the participant's log.

Secondary

MeasureTime frameDescription
Fasting blood glucose levelsbaseline, daily for 6 daysThis outcome will be assessed from the CGM data recorded after a10 hour fast.
Post prandial glucose levelsbaseline, daily for 6 daysThis outcome will be assessed from the CGM data recorded daily 4 hours after a study meal.

Contacts

CONTACTNicole L Spartano, PhD
spartano@bu.edu315-415-2040
CONTACTBahar Bakshi, MS
baharb@bu.edu(315) 415-2040
PRINCIPAL_INVESTIGATORNicole L Spartano, PhD

BUCA School of Medicine, Endocrinology, Diabetes, Nutrition and Weight Management

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026